The Brooklyn Hospital Center is a 464-licensed-bed, full-service community teaching hospital located in Downtown Brooklyn, New York City. The hospital was founded in 1845. It is affiliated with the Mount Sinai Health System, and serves a diverse population from a wide range of ethnic backgrounds.

There are 464 beds in Brooklyn Hospital Center.

During the past decade, Brooklyn Hospital Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 26 clinical trials were completed, i.e. on average, 236.4% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Brooklyn Hospital Center" #1 sponsor was "Children's Oncology Group" with 53 trials, followed by "The Brooklyn Hospital Center" with 5 trials sponsored, "National Cancer Institute (NCI)" with 4 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored and "Shire" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brooklyn Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Canadian Blood Services" with 1 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Brooklyn Hospital Center" are "Leukemia" (10 trials), "Lymphoma" (7 trials), "Sarcoma" (7 trials), "Major Depressive Disorder" (5 trials) and "Acute Lymphoblastic Leukemia" (4 trials). Many other conditions were trialed in "Brooklyn Hospital Center" in a lesser frequency.

Most popular intervention types in "Brooklyn Hospital Center" are "Drug" (69 trials), "Other" (23 trials), "Biological" (21 trials), "Radiation" (21 trials) and "Procedure" (17 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (14 trials), "etoposide" (12 trials), "filgrastim" (12 trials), "Laboratory Biomarker Analysis" (11 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "Brooklyn Hospital Center" are 88 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Brooklyn Hospital Center". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Brooklyn Hospital Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Brooklyn Hospital Center, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".